BHCM
AXNX

Brevan Howard Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Brevan Howard Capital Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,420
Closed -$725K – 1524
2024
Q3 		$725K Buy
10,420
+6,278
+152% +$431K 0.01% 565
2024
Q2 		$278K Buy
+4,142
New +$279K ﹤0.01% 803

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Brevan Howard Capital Management's AXNX Position: Q4 2024 in Review

Brevan Howard Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 10,420 shares — an estimated $725K sold.

Brevan Howard Capital Management first reported a position in AXNX in Q2 2024 and held it in 2 quarters. The position peaked at $725K in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Brevan Howard Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Brevan Howard Capital Management sold 10,420 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $725K.
  • Brevan Howard Capital Management first reported a position in Axonics, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • Brevan Howard Capital Management's Axonics, Inc. Common Stock position peaked at $725K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Brevan Howard Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.